All community pharmacist articles
-
Independent professional body guidelineBASHH vulvovaginal candidiasis guideline
Recommendations on the diagnostic tests, treatment regimens, and health promotion principles for the effective management of vulvovaginal candidiasis
-
NICE guideline
NICE antimicrobial prescribing guideline for insect bites and stings
This Guidelines summary covers an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people, and children
-
News
GP referrals to Community Pharmacist Consultation Service to start this autumn
Following a pilot scheme, the PSNC has agreed proposals that GP referrals into the CPCS should begin in the autumn
-
Information
OTC quick reference guide
A quick reference tool summarising CCG guidance on conditions for which over-the-counter items should not routinely be prescribed in primary care.
-
NICE guideline
NICE CKS Otitis externa
Covering diagnosis, management, and topical treatments for inflammation of the external ear canal
-
Independent professional body guideline
PSNC Seasonal flu service specification
NHS England and NHS Improvement has commissioned an advanced service for community pharmacies to provide flu vaccinations in order to improve access to NHS flu vaccination for eligible patients
-
NICE guideline
Community pharmacies: promoting health and wellbeing
This quality standard covers how community pharmacies can support the health and wellbeing of the local population, and describes high-quality care in priority areas for improvement
-
News
London pharmacies aim to make capital healthier under new strategy
New strategy to make community pharmacy instrumental in London’s health and social care
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19.
-
NHS guideline
NHS England COVID-19 community pharmacy guideline
This standard operating proedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
-
PHE/DH/DWP guideline
PHE influenza immunisation 2020/21 guideline
This Guidelines summary covers key information on expansion of the 2020-21 flu immunisation programme.
-
NICE guideline
NICE CKS analgesia—mild-to-moderate pain
An overview of the analgesics available to treat mild-to-moderate pain in different patient cohorts.
-
NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
-
SIGN guideline
SIGN osteoporosis guideline
A brief summary of SIGN's guideline on management of osteoporosis and prevention of fragility fractures, including risk factors and a treatment algorithm.
-
Information
Key COVID-19 guidance for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
-
Independent professional body guideline
BTS/SIGN asthma in pregnancy guideline
This summary focuses on recommendations for the management of asthma in pregnant women, including during labour, and recommendations for breastfeeding mothers
-
PHE/DH/DWP guideline
PHE guideline on management of exposure to COVID-19
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
-
Information
GINA ASTHMA STRATEGY 2020
Asthma affects an estimated 300 million individuals worldwide, and still imposes an unacceptable burden on healthcare systems, society through loss of productivity in the workplace, and, especially for paediatric asthma, disruption to the family. Asthma affects all age groups and contributes to many deaths worldwide. The Global Initiative for ...
-
Independent professional body guideline
GINA strategy 2020: diagnosis of asthma
This Guidelines summary outlines recommendations for making the diagnosis of asthma in adults and children over five years of age. Please refer to the full report for the complete set of recommendations.
-
Independent professional body guideline
BTS/SIGN management of difficult asthma guideline
This brief summary of BTS/SIGN guidance on the assessment and management of difficult asthma includes information on contributory factors and monitoring.
